Cancer screening: The importance of outcome measures

Critical Reviews in Oncology/Hematology

Volumn 57, Issue 3, 2006, Pages 215-224

  Alibhai, Shabbir M H ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Bias (epidemiology); Cancer screening; Outcomes

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANXIETY; AUTOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STATISTICS; CAUSE OF DEATH; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE FREE SURVIVAL; ECHOGRAPHY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRECANCER; PROSTATE CANCER; QUALITY OF LIFE; RADIODIAGNOSIS; REVIEW; SIGMOIDOSCOPY; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CARCINOMA IN SITU;

COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; NEOPLASMS; QUALITY OF LIFE; RESEARCH DESIGN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 32544456269     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2005.08.002     Document Type: Review

References (51)

1. K. Kerlikowske, P. Salzmann, K.A. Phillips, J.A. Cauley, and S.R. Cummings Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness JAMA 282 22 1999 2156 2163
2. US Preventive Services Task Force. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002;137(5 Part 1):344-6.
3. G.F. Sawaya, A.D. Brown, A.E. Washington, and A.M. Garber Clinical practice. Current approaches to cervical-cancer screening N Engl J Med 344 21 2001 1603 1607
4. R. Harris, and K.N. Lohr Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 11 2002 917 929
5. Anon. Recruitment begins for lung cancer screening trial. J Natl Cancer Inst 2002;94(21):1603.
6. P.C. Prorok, J. Chamberlain, N.E. Day, M. Hakama, and A.B. Miller UICC Workshop on the evaluation of screening programmes for cancer Int J Cancer 34 1 1984 1 4
7. A. Barratt, L. Irwig, and P. Glasziou Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group JAMA 281 21 1999 2029 2034
8. L.C. Walter, and K.E. Covinsky Cancer screening in elderly patients: a framework for individualized decision making JAMA 285 21 2001 2750 2756
9. J.M. Last A Dictionary of Epidemiology 2nd ed. 1988 Oxford University Press New York
10. C.R. Smart Screening and early diagnosis Cancer 70 Suppl. 5 1992 1246 1251
11. R. Montironi, R. Mazzucchelli, J.R. Marshall, and P.H. Bartels Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents J Clin Pathol 52 11 1999 793 803
12. R.L. Prentice Surrogate endpoints in clinical trials: definition and operational criteria Stat Med 8 4 1989 431 440
13. W.A. Satariano, and D.R. Ragland The effect of comorbidity on 3-year survival pf women with primary breast cancer Ann Intern Med 120 2 1994 104 110
14. P. Cole, and A.S. Morrison Basic issues in population screening for cancer J Natl Cancer Inst 64 5 1980 1263 1272
15. dos Santos Silva I. Cancer prevention. Cancer Epidemiology. Lyon: International Agency for Research on Cancer; 1999. p. 355-80.
16. J.S. Mausner, and S. Kramer Epidemiology. An Introductory Text 2nd ed. 1985 W.B. Saunders Company Philadelphia
17. G. Lu-Yao, P.C. Albertsen, J.L. Stanford, T.A. Stukel, E.S. Walker-Corkery, and M.J. Barry Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut BMJ 325 7367 2002 740
18. R. Etzioni, D.F. Penson, and J.M. Legler Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends J Natl Cancer Inst 94 13 2002 981 990
19. A.B. Miller Fundamental issues in screening for cancer D. Schottenfeld J.F. Fraumeni Jr. Cancer Epidemiology and Prevention 2nd ed 1996 Oxford University Press New York 1521
20. E.L. Paquette, L. Sun, L.R. Paquette, R. Connelly, D.G. McLeod, and J.W. Moul Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing Urology 60 5 2002 756 759
21. Screening C.H. Hennekens J.E. Buring Epidemiology in Medicine 1987 Little, Brown and Company Boston 383
22. A.J. Sasco Lead time and length bias in case-control studies for the evaluation of screening J Clin Epidemiol 41 1 1988 103 104
23. M. Tornblom, H. Eriksson, and S. Franzen Lead time associated with screening for prostate cancer Int J Cancer 108 1 2004 122 129
24. A.S. Morrison The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening Int J Epidemiol 11 3 1982 261 267
25. S.D. Walter, and N.E. Day Estimation of the duration of a pre-clinical disease state using screening data Am J Epidemiol 118 6 1983 865 886
26. S.D. Walter, and L.W. Stitt Evaluating the survival of cancer cases detected by screening Stat Med 6 8 1987 885 900
27. S. Shapiro Evidence on screening for breast cancer from a randomized trial Cancer 39 Suppl. 6 1977 2772 2782
28. M.R. Greenlick, J.W. Bailey, J. Wild, and J. Grover Characteristics of men most likely to respond to an invitation to be screened Am J Public Health 69 10 1979 1011 1015
29. C. Percy, E. Stanek, and L. Gloeckler Accuracy of cancer death certificates and its effect on cancer mortality statistics Am J Public Health 71 1981 242 250
30. C.S. Moy, D.M. Albert, M. Diener-West, L.D. McCaffrey, R.E. Scully, and J.K. Willson Cause-specific mortality coding, methods in the collaborative ocular melanoma study COMS report no. 14 Control Clin Trials 22 3 2001 248 262
31. R.M. Hoffman, S.N. Stone, W.C. Hunt, C.R. Key, and F.D. Gilliland Effects of misattribution in assigning cause of death on prostate cancer mortality rates Ann Epidemiol 3 6 2003 450 454
32. W.C. Black, D.A. Haggstrom, and H.G. Welch All-cause mortality in randomized trials of cancer screening J Natl Cancer Inst 94 3 2002 167 173
33. R.H. Fletcher, S.W. Fletcher, and E.H. Wagner Clinical Epidemiology: The Essentials 2nd ed. 1988 Williams & Wilkins Baltimore
34. D.L. Sackett, R.B. Haynes, G.H. Guyatt, and P. Tugwell Clinical Epidemiology: A Basic Science for Clinical Medicine 2nd ed. 1991 Little, Brown and Company Toronto
35. E.A. Clarke, and T.W. Anderson Does screening by "Pap" smears help prevent cervical cancer? A case-control study Lancet 2 8132 1979 1 4
36. N. Aristizabal, C. Cuello, P. Correa, T. Collazos, and W. Haenszel The impact of vaginal cytology ion cervical cancer risks in Cali, Colombia Int J Cancer 34 1 1984 5 9
37. C. La Vecchia, S. Franceschi, A. Decarli, M. Fasoli, A. Gentile, and G. Tognoni "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study Lancet 2 8406 1984 779 782
38. J.E. Macgregor, S.M. Moss, D.M. Parkin, and N.E. Day A case-control study of cervical cancer screening in north east Scotland Br Med J (Clin Res Ed) 290 6481 1985 1543 1546
39. Y. van der Graaf, G.A. Zielhuis, P.G. Peer, and P.G. Vooijs The effectiveness of cervical screening: a population-based case-control study J Clin Epidemiol 41 1 1988 21 26
40. O.W. Brawley, and B.S. Kramer Cancer screening in theory and in practice J Clin Oncol 23 2 2005 293 300
41. D. Saslow, C.D. Runowicz, and D. Solomon American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 6 2002 342 362
42. A.S. Morrison, J. Brisson, and N. Khalid Breast cancer incidence and mortality in the breast cancer detection demonstration project J Natl Cancer Inst 80 19 1988 1540 1547
43. J.M. Walsh, and J.P. Terdiman Colorectal cancer screening: scientific review JAMA 289 10 2003 1288 1296
44. M. Krahn, and G. Naglie Principles of economic evaluation in cancer screening A.B. Miller Advances in Cancer Screening 1996 Kluwer Academic Publishers Boston 25 40
45. A. Sonnenberg, F. Delco, and J.M. Inadomi Cost-effectiveness of colonoscopy in screening for colorectal cancer Ann Intern Med 133 8 2000 573 584
46. M.D. Krahn, J.E. Mahoney, M.H. Eckman, J. Trachtenberg, S.G. Pauker, and A.S. Detsky Screening for prostate cancer - a decision analytic view JAMA 272 10 1994 773 780
47. C. Lerman, B. Trock, B.K. Rimer, A. Boyce, C. Jepson, and P.F. Engstrom Psychological and behavioral implications of abnormal mammograms Ann Intern Med 114 8 1991 657 661
48. S.J. Winawer, R.H. Fletcher, and L. Miller Colorectal cancer screening: clinical guidelines and rationale Gastroenterology 112 2 1997 594 642
49. R.B. Haynes, D.L. Sackett, D.W. Taylor, E.S. Gibson, and A.L. Johnson Increased absenteeism from work after detection and labeling of hypertensive patients N Engl J Med 299 14 1978 741 744
50. J.G. Elmore, M.B. Barton, V.M. Moceri, S. Polk, P.J. Arena, and S.W. Fletcher Ten-year risk of false positive screening mammograms and clinical breast examinations N Engl J Med 338 16 1998 1089 1096
51. P.A. Singer, E.S. Tasch, C. Stocking, S. Rubin, M. Siegler, and R. Weichselbaum Sex or survival: trade-offs between quality and quantity of life J Clin Oncol 9 1991 328 334